Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-6)

Sum=100

Publishing Process of This Article

Item

Count

Browse

Download

Sum=25

Jan 19, 2025 (publication date) through Dec 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Psychiatry. Jan 19, 2025; 15(1): 98737
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98737

Table 5 Comparison of adverse reactions during the intervention period, n (%)

Group	Urodynia	Hematuria	Dysuria	Frequent and urgent urination	Total incidence (%)
Conventional group (n = 55)	7 (12.73)	5 (9.01)	4 (5.33)	6 (10.91)	22 (40.00)
Joint intervention group (n = 55)	4 (5.33)	2 (3.64)	2 (3.64)	3 (5.45)	11 (20.00)
χ²					5.238
P value					0.022

Citation: Liu J, Guo YP, Lu YM, Wang BL. Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression. World J Psychiatry 2025; 15(1): 98737
URL: https://www.wjgnet.com/2220-3206/full/v15/i1/98737.htm
DOI: https://dx.doi.org/10.5498/wjp.v15.i1.98737